Provision of Prosigna Kits

A Voluntary Ex-Ante Transparency (VEAT) Notice
by THE ROYAL MARSDEN NHS FOUNDATION TRUST

Source
Find a Tender
Type
Contract (Supply)
Duration
not specified
Value
£240K
Sector
HEALTH
Published
01 Dec 2021
Delivery
not specified
Deadline
n/a

Concepts

Location

London

Geochart for 2 buyers and 1 suppliers

2 buyers

1 supplier

Description

The Royal Marsden needs to purchase Prosina kits from Veracyte. The kit is a genetic test that gives an indication of how likely it is that a patient with breast cancer will experience a recurrence of their disease, and this informs clinicians on the best treatment for their patient. This will be a two years term. Veracyte are the sole supplier of this product

Award Detail

1 Veracyte (San Francisco)
  • Value: £240,000

CPV Codes

  • 33000000 - Medical equipments, pharmaceuticals and personal care products

Indicators

  • Award on basis of price and quality.

Other Information

Suppliers Awarded is Veracyte, Inc.

Reference

Domains